Immutep IMMP
NASDAQ IMMP
$4.54 -0.11 (-2.37%)
At close: Oct 1, 2026 · 4:00 PM EDT

Immutep (IMMP) Accumulated Expenses (2025)

Updated

Immutep (IMMP) reported Accumulated Expenses of $6.73 million for the quarter ended Dec 31, 2025.

Analysis

Immutep (IMMP) Accumulated Expenses (2025) Analysis & Trends

As of Jun 30, 2025, Immutep posted Accumulated Expenses of $2.98 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Immutep 33.95 Mn 33.95 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 6.73 Mn
Jun 30, 2025 2.98 Mn
API Access

Immutep Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=IMMP&period=max&api_key=YOUR_API_KEY